Top Stories
The Australian company's AI model aims to generate predictive risk scores for heart failure using echocardiographic data.
Clairyon's COMPOSER model will draw on SEQSTER's patient records, lab results, genomics and wearable data to spot sepsis before patients are already in danger.
Guardant360 CDx can now be used as a blood-based companion diagnostic for Boehringer Ingelheim's Hernexeos, a targeted treatment for HER2-mutant advanced NSCLC.
The venture capital firm is targeting early and growth-stage companies focused on interventional therapies, diagnostics, monitoring and the digitalisation of healthcare.
The new system can identify more than 100 molecular subtypes of central nervous system tumours using standard tissue sections.
Conference News
Saudi Arabia Emerges as a Global Biotech Investment Hub Under Vision 2030Senior Saudi Government, Investment and Healthcare Leaders to Attend the CEL-SCI / Amarox Signing & Opening CeremoniesStrategic...
12 Jun 2026Multi-regional modelling reveals new ways to personalise treatments in gastric and breast cancers Intratumoural heterogeneity has emerged as an extremely relevant clinical marker, and in HE...
Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, will be prominently featured at SLEEP 2026. The medtech company will showcase its innovative technology at booth #600, prese...
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its partici...
GDANSK, Poland and MANCHESTER, England, June 11, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 11th that it hosted exclusive symposiums at the 35th European Society of Hypert...
